2021

26/02/2021

Exercise of Options

 25/02/2021

Appendix 4D and Interim Financial Report

 16/02/2021

Response to Price Query

 08/02/2021

Proteomics International seeks FDA approval for PromarkerD

 28/01/2021

Update – Proposed issue of Securities – PIQ

 28/01/2021

Issue of Options and Secondary Trading Notice

 28/01/2021

Results of Meeting

 28/01/2021

Appendix 4C – December 2021 Quarterly Update

Investors

ASX Announcements

2021 2020 2019 2018 2017 2016 2015
Subscribe
  • This field is for validation purposes and should be left unchanged.
Menu